heart iconheart icon
Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Jan 2, 2018
NEW BRUNSWICK, N.J., Jan. 2, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2018 of $0.84 per share on the company's common stock. The dividend is payable on March 13, 2018 to shareholders of record at the close of business on February 27, 2018. Th...
Dec 21, 2017
HORSHAM, Pa., Dec. 21, 2017 /PRNewswire/ -- Janssen Biotech, Inc. ("Janssen"), a Janssen Pharmaceutical Company of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. and Legend Biotech Ireland Limited ("Legend"), subsidiaries of Genscript Biotech Corporation, to d...
Dec 21, 2017
HORSHAM, Pa., Dec. 21, 2017 /PRNewswire/ -- Janssen Biotech, Inc. (Janssen) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation for the New Drug Application (NDA) for apalutamide, an investigational, next-generation oral androgen receptor (AR) inhibitor for the treatment of men with non-metastati...
Dec 19, 2017
NEW BRUNSWICK, N.J., Dec. 19, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 36th Annual JP Morgan Health Care Conference on Monday, Jan. 8, at the Westin St. Francis in San Francisco.  Alex Gorsky, Chairman and Chief Executive Officer, will represent the Company in a session scheduled at 2:30 p.m. (Pacific Time)/5:30 p....
Dec 19, 2017
NEW BRUNSWICK, N.J., Dec. 19, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, January 23rd, to review fourth-quarter results.  Alex Gorsky, Chairman and Chief Executive Officer; Dominic Caruso, Executive Vice President, Chief Financial Officer and Joseph J. Wolk, V...
Dec 12, 2017
Dec 11, 2017
Dec 9, 2017
Dec 5, 2017
Nov 30, 2017
NEW BRUNSWICK, N.J., Nov. 30, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the BMO Capital Markets Healthcare Conference on Thursday, Dec. 14, at the Westin Grand Central, in New York, NY.  Sandi Peterson, Executive Vice President, Group Worldwide Chairman will represent the Company in a session scheduled at 8:30 a.m. (Eas...
Page:
1
... NextLast
= add release to Briefcase